Anastrozole dose escalation for optimal estrogen suppression in postmenopausal early stage breast cancer: A prospective trial

被引：1
|
作者：
Haddad, Tufia C.
Suman, Vera
Giridhar, Karthik V.
Moreno-Aspitia, Alvaro
Northfelt, Donald
Ernst, Brenda
Sideras, Kostandinos
O'Sullivan, Ciara C.
Singh, Ravinder
Desta, Zeruesenay
Taraba, Jodi
Goodnature, Barbara
Goetz, Matthew P.
Wang, Liewei
Ingle, James N.
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 05期
关键词：
D O I：
10.1158/1538-7445.SABCS22-OT1-04-02
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OT1-04-02
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Low-dose-rate interstitial implants for early stage breast cancer: Outcomes and late toxicity of a dose escalation study
    MacDonald, S. I.
    El-Din, M. A. Alm
    Smith, B. L.
    Gadd, M. A.
    Ancukiewicz, M.
    Powell, S.
    Taghian, A. G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S144 - S144
  • [32] Influence of compliance on bone mineral density changes in postmenopausal women with early breast cancer on Anastrozole
    Matthias Kalder
    Volker Ziller
    Ioannis Kyvernitakis
    Dana Knöll
    Olaf Hars
    Peyman Hadji
    Journal of Cancer Research and Clinical Oncology, 2013, 139 : 915 - 923
  • [33] Suppression of Plasma Estrogen Levels by Letrozole and Anastrozole Is Related to Body Mass Index in Patients With Breast Cancer
    Folkerd, Elizabeth J.
    Dixon, J. Michael
    Renshaw, Lorna
    A'Hern, Roger P.
    Dowsett, Mitch
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (24) : 2977 - 2980
  • [34] Prospective Evaluation of Joint Symptoms in Postmenopausal Women Initiating Aromatase Inhibitors for Early Stage Breast Cancer
    Crew, K. D.
    Chehayeb, Makarem D.
    Awad, D.
    Kalinsky, K.
    Maurer, M.
    Kranwinkel, G.
    Brafman, L.
    Fuentes, D.
    Hershman, D. L.
    CANCER RESEARCH, 2012, 72
  • [35] Prospective Evaluation of Joint Symptoms in Postmenopausal Women Initiating Aromatase Inhibitors for Early Stage Breast Cancer
    Crew, K. D.
    Podolanczuk, A.
    Brafman, L.
    Awad, D.
    Hershman, D. L.
    CANCER RESEARCH, 2009, 69 (24) : 779S - 779S
  • [36] Preclinical evaluation for dose escalation in the preoperative SBRT of early breast cancer
    Piccolo, C.
    Zerella, M. A.
    Rondi, E.
    Vigorito, S.
    Ferrari, A. M.
    Veronesi, P.
    Galimberti, V.
    Orecchia, R.
    Cattani, F.
    Jereczek-Fossa, B. A.
    Leonardi, M. C.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S913 - S914
  • [37] Three-Year Cosmetic Outcomes of a Phase I Dose Escalation Trial of 5-Fraction Stereotactic Partial Breast Irradiation for Early Stage Breast Cancer
    Morgan, H. E.
    Kim, D. N.
    Zhang, Y.
    Leitch, M.
    Wooldridge, R.
    Seiler, S.
    Goudreau, S.
    Haley, B.
    Rao, R.
    Rivers, A.
    Spangler, A. E.
    Jones, R. T.
    Stevenson, S.
    Staley, J.
    Ahn, C.
    Albuquerque, K. V.
    Gu, X.
    Zhao, B.
    Timmerman, R. D.
    Rahimi, A. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E15 - E16
  • [38] Escalation and De-Escalation Strategies for Endocrine Therapy in Early-Stage Breast Cancer
    Al-Batsh, Tamer
    Abdel-Razeq, Nayef
    Al-Masri, Yosra
    El-Khatib, Osama
    Sharaf, Baha
    Tamimi, Faris
    Abdel-Razeq, Hikmat
    BIOLOGICS-TARGETS & THERAPY, 2025, 19 : 97 - 111
  • [39] Anastrozole is superior to tamoxifen in the treatment of postmenopausal women with early breast cancer - first results of the ATAC ('Arimidex', Tamoxifen, alone or in combination) trial
    Sainsbury, R
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 137 - 137
  • [40] ACOSOG Z1031: A randomized phase II trial comparing exemestane, letrozole, and anastrozole in postmenopausal women with clinical stage II/III estrogen receptor-positive breast cancer
    Ellis, M. J.
    Babiera, G.
    Unzeitig, G. W.
    Marcom, P. K.
    Guenther, J. M.
    Deshryver, F. K.
    Allred, D. C.
    Suman, V.
    Hunt, K.
    Olson, J. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (18)
12345